0001209191-23-016714.txt : 20230307
0001209191-23-016714.hdr.sgml : 20230307
20230307161141
ACCESSION NUMBER: 0001209191-23-016714
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sabag Mark
CENTRAL INDEX KEY: 0001721442
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 23712716
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-03
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001721442
Sabag Mark
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 DVORA HANEVI'A ST.,
TEL AVIV
L3
6944020
ISRAEL
0
1
0
0
EVP, International Markets
Ordinary Shares
2023-03-04
4
M
0
33512
A
281997
D
Ordinary Shares
2023-03-04
4
M
0
15921
A
297918
D
Ordinary Shares
2023-03-05
4
M
0
23764
A
321682
D
Restricted Share Units
2023-03-03
4
A
0
99601
0.00
A
Ordinary Shares
99601
99601
D
Restricted Share Units
2023-03-04
4
M
0
15921
0.00
D
Ordinary Shares
15921
0
D
Restricted Share Units
2023-03-04
4
M
0
33512
0.00
D
Ordinary Shares
33512
100536
D
Restricted Share Units
2023-03-05
4
M
0
23764
0.00
D
Ordinary Shares
23764
47529
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources
and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
Restricted share units were granted on March 4, 2019, with 15,920 vested on each of March 4, 2021 and March 4, 2022, and 15,921 vested on March 4, 2023.
Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
Restricted share units were granted on March 5, 2021, with 23,764 vested on each of March 5, 2022 and March 5, 2023, 23,764 vesting on March 5, 2024, and 23,765 vesting on March 5, 2025.
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
2023-03-07